Mingxia Ding
Papers
1
Total Citations
13
H-Index
1
About
Mingxia Ding is a prominent researcher in urologic oncology, with a primary focus on advancing surgical techniques for bladder cancer treatment. Her work centers on evaluating and comparing the effectiveness and safety of robot-assisted radical cystectomy (RARC), particularly when combined with intracorporeal urinary diversion (iRARC), against traditional open surgery. Ding’s major contribution lies in providing rigorous, evidence-based assessments through systematic reviews and meta-analyses that clarify the clinical outcomes of these minimally invasive approaches. Her most cited paper, a 2024 systematic review and meta-analysis on iRARC, has garnered 13 citations, reflecting its timely relevance in a rapidly evolving field. This work critically examines perioperative outcomes, helping to resolve ongoing debates about whether robotic techniques offer tangible advantages over open surgery. By synthesizing data from multiple studies, Ding has helped guide clinical decision-making for surgeons and patients alike. Her research is notable for its methodological rigor and its direct impact on urological practice, positioning her as a key voice in the transition toward minimally invasive bladder cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1